New Injectable
Recently the Food and Drug Administration (FDA) has approved a new injectable antibody called dumilumab (Dupixent). This new medication is used to treat the severe diseases that do not respond well to other treatments. Although enough human research regarding its effectiveness in helping people is not available, studies have shown it to be safe for use.